These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17079247)

  • 41. Thrombovascular events affect quality of life in patients with systemic lupus erythematosus.
    Balitsky AK; Peeva V; Su J; Aghdassi E; Yeo E; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2011 Jun; 38(6):1017-9. PubMed ID: 21362766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased diffusion capacity on lung function testing in asymptomatic patients with systemic lupus erythematosus does not predict future lung disease.
    Elalouf O; Fireman E; Levartovsky D; Kaufman I; Rogovski O; Elkayam O; Caspi D; Paran D
    Lupus; 2015 Aug; 24(9):973-9. PubMed ID: 25595620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of lung perfusion scintigraphic findings in pulmonary thromboembolism in systemic lupus erythematosus, SLE plus antiphospholipid syndrome, and primary antiphospholipid syndrome.
    Aung W; Murata Y; Ishida R; Shibuya H
    Nucl Med Commun; 2000 Mar; 21(3):299-304. PubMed ID: 10823333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.
    Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
    Semin Arthritis Rheum; 2018 Jun; 47(6):883-889. PubMed ID: 29150207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
    Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O
    J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.
    Pardos-Gea J; Cortés-Hernández J; Castro-Marrero J; Balada E; Ordi-Ros J
    Clin Rheumatol; 2017 Jun; 36(6):1401-1406. PubMed ID: 28283766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disease chronicity and activity predict subclinical left ventricular systolic dysfunction in patients with systemic lupus erythematosus.
    Yip GW; Shang Q; Tam LS; Zhang Q; Li EK; Fung JW; Yu CM
    Heart; 2009 Jun; 95(12):980-7. PubMed ID: 19240052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signs of impaired immunoregulation and enhanced effector T-cell responses in the primary antiphospholipid syndrome.
    Jakiela B; Iwaniec T; Plutecka H; Celinska-Lowenhoff M; Dziedzina S; Musial J
    Lupus; 2016 Apr; 25(4):389-98. PubMed ID: 26657472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.
    Paule R; Morel N; Le Guern V; Fredi M; Coutte L; Belhocine M; Mouthon L; le Jeunne C; Chauvin A; Piette JC; Costedoat-Chalumeau N
    Autoimmun Rev; 2018 Sep; 17(9):866-872. PubMed ID: 30005859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
    Merrill JT
    Lupus; 2004; 13(11):869-76. PubMed ID: 15580985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.
    Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D
    J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
    Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Bundhun PK; Boodhoo KD; Long MY; Chen MH
    Medicine (Baltimore); 2016 Mar; 95(12):e3200. PubMed ID: 27015221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
    Blanco Y; Ramos-Casals M; García-Carrasco M; Cervera R; Font J; Ingelmo M
    Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study.
    Pardos-Gea J; Avegliano G; Evangelista A; Vilardell M; Ordi-Ros J
    Int J Rheum Dis; 2015 Jan; 18(1):76-83. PubMed ID: 24131635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.